drugset / Trial / NCT02322749
A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers
RandomizedCrossoverOpen-labelBasic science
Summary
A Study to assess, against a reference selumetinib capsule, if the drug levels of a variant of selumetinib capsule are comparable, and to assess how drug levels differed in another variant of Selumetinib in Healthy Male Volunteers.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selumetinib | Small molecule | 75 mg | Oral |
Indications
No indication recorded.